Хайлтын үр дүнгүүд

Neoplastic disease after liver transplantation: Focus on<i>de novo</i>neoplasms -н Patrizia Burra

Бүрэн текст авах

Recent advances in the treatment of metastatic renal cell carcinoma -н Hideyuki Abe, Takao Kamai

Бүрэн текст авах

Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer -н Helen Mackay, Elizabeth A. Eisenhauer, Suzanne Kamel‐Reid, Ming‐Sound Tsao, Blaise Clarke, Katherine Karakasis, Henrica M.J. Werner, Jone Trovik, Lars A. Akslen, Helga B. Salvesen, Dongsheng Tu, Amit M. Oza

Бүрэн текст авах Бүрэн текст авах

The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models -н Patrick L. Garcia, Aubrey L. Miller, Kelly M. Kreitzburg, Leona N. Council, Tracy L. Gamblin, John D. Christein, Marty J. Heslin, J. Pablo Arnoletti, Joseph H. Richardson, D Chen, C. Alexandra Hanna, S L Cramer, Eddy S. Yang, Jun Qi, James E. Bradner, Karina J. Yoon

Бүрэн текст авах

Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial -н Tatiana Schneider, Djoeke de Wit, Th. P. Links, Nielka P. van Erp, J. J. M. van der Hoeven, Hans Gelderblom, Tom van Wezel, Ronald van Eijk, Hans Morreau, Henk‐Jan Guchelaar, Ellen Kapiteijn

Бүрэн текст авах Бүрэн текст авах

Therapeutic mTOR Inhibition in Autosomal Dominant Polycystic Kidney Disease: What Is the Appropriate Serum Level? -н Guillaume Canaud, Bertrand Knebelmann, Peter C. Harris, François Vrtovsnik, J.M. Corréas, Nicolas Pallet, C Heyer, Emmanuel Letavernier, Frank Bienaimé, Éric Thervet, F. Martinez, Fabiola Terzi, Christophe Legendre

Бүрэн текст авах Бүрэн текст авах

Temsirolimus, an mTOR inhibitor, in combination with lower‐dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (... -н Sergio Amadori, Roberto Stasi, Alberto M. Martelli, Adriano Venditti, Giovanna Meloni, Fabrizio Pane, Giovanni Martinelli, Monia Lunghi, Livio Pagano, Daniela Cilloni, Elena Rossetti, Francesco Di Raimondo, Claudio Fozza, Luciana Annino, Francesca Chiarini, Francesca Ricci, Emanuele Ammatuna, Edoardo La Sala, Paola Fazi, Marco Vignetti

Бүрэн текст авах Бүрэн текст авах

Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: A report from the children's oncology gr... -н Lars M. Wagner, Maryam Fouladi, Atif Ahmed, Mark Krailo, Brenda J. Weigel, Steven G. DuBois, L. Austin Doyle, Helen Chen, Susan M. Blaney

Бүрэн текст авах

Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients -н Angela C Webster, Vincent Lee, Jeremy R. Chapman, Jonathan C. Craig

Бүрэн текст авах

Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge -н Martin‐Walter Welker, Wolf O. Bechstein, Stefan Zeuzem, Joerg Trojan

Бүрэн текст авах Бүрэн текст авах

Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response -н Winnie Yeo, Stephen L. Chan, Frankie Mo, Cheuk Man Chu, J. Hui, Joanne HM Tong, Anthony W.H. Chan, Jane Koh, Edwin P. Hui, Herbert H. Loong, Kirsty Lee, Leung Li, Brigette Ma, Ka‐Fai To, Simon C.H. Yu

Бүрэн текст авах Бүрэн текст авах

Mechanistic target of rapamycin (mTOR) expression is increased in acne patients' skin -н Giuseppe Monfrecola, Serena Lembo, Giuseppina Caiazzo, Valerio De Vita, Roberta Di Caprio, Anna Balato, Gabriella Fabbrocini

Бүрэн текст авах Бүрэн текст авах

Doubling Down on the PI3K-AKT-mTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness -н Pradip De, Yuling Sun, Jennifer Carlson, Lori S. Friedman, Brian Leyland‐Jones, Nandini Dey

Бүрэн текст авах

Toward rapamycin analog (rapalog)-based precision cancer therapy -н Linghua Meng, X.F. Steven Zheng

Бүрэн текст авах Бүрэн текст авах

Neratinib (N) with or Without Temsirolimus (Tem) in Patients (Pts) with Non-Small Cell Lung Cancer (Nsclc) Carrying Her2 Somatic Mutations: an International Randomized Phase Ii Stu... -н Benjamin Besse, J.C. Soria, Bin Yao, Mark G. Kris, Bo H. Chao, Alexis B. Cortot, Julien Mazières, Mark A. Socinski, Leora Horn, Saiama N. Waqar, Fabrice Barlési, Jhanelle E. Gray, Denis Moro‐Sibilot, Ana B. Oton, Élisabeth Quoix, Alshad S. Lalani, Leanne McCulloch, Richard Bryce, Leena Gandhi

Бүрэн текст авах Бүрэн текст авах

Olive Oil‐derived Oleocanthal as Potent Inhibitor of Mammalian Target of Rapamycin: Biological Evaluation and Molecular Modeling Studies -н Mohammad A. Khanfar, Sanaa K. Bardaweel, Mohamed R. Akl, Khalid A. El Sayed

Бүрэн текст авах

Analysis of <i>mTOR</i> Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K–AKT–mTOR Pathway Inhibitors -н Yan Kong, Lu Si, Yiqian Li, Xiaowen Wu, Xiaowei Xu, Jie Dai, Huan Tang, Meng Ma, Zhihong Chi, Xinan Sheng, Chuanliang Cui, Jun Guo

Бүрэн текст авах

Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncol... -н Rochelle Bagatell, Robin E. Norris, Ashish M. Ingle, Charlotte H. Ahern, Stephan D. Voss, Elizabeth Fox, Anthony Little, Brenda J. Weigel, Peter C. Adamson, Susan M. Blaney

Бүрэн текст авах

Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus -н Elisabeth Mlczoch, Andreas Hanslik, Doris Luckner, Erwin Kitzmüller, Daniela Prayer, Ina Michel‐Behnke

Бүрэн текст авах Бүрэн текст авах

Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer -н Sreedhar Venkannagari, Warren Fiskus, Karissa Peth, Peter Atadja, Manuel Hidalgo, Anirban Maitra, Kapil N. Bhalla

Бүрэн текст авах Бүрэн текст авах